Key Takeaways
- • Former hedge fund manager Jim Pulaski purchased a unit at Apogee in South Beach, marking the first closing at the luxury property in nearly two years, according to the co-listing brokerage.
- • The transaction was facilitated by the sale of a French real estate family's condo unit at Apogee, indicating continued activity in Miami Beach's ultra-luxury residential market despite the extended sales gap.
- • Apogee remains a flagship South Beach development attracting high-net-worth buyers, including hedge fund managers and institutional finance professionals, with recent recorded transactions ranging from $8.4 million to $16.95 million listed.
- • Pulaski's purchase follows his sale of a waterfront North Bay Road mansion, representing a strategic portfolio shift toward South Beach's most prestigious oceanfront developments.
Summary
Pulaski's acquisition of the Apogee unit followed his sale of a waterfront North Bay Road mansion, suggesting a deliberate repositioning of his real estate holdings toward South Beach's premium oceanfront corridor. The transaction aligns with broader activity at Apogee, where other notable acquisitions have included purchases by hedge fund-affiliated buyers and institutional finance professionals. Recent market activity at the development has included a $13.5 million sale to a Connecticut-based hedge fund manager and separate purchases by Edward Rose, Vice Chairman of Maxim Group, for $9.3 million.
Apogee, located at 800 South Pointe Drive in Miami Beach, continues to command significant valuations in the ultra-high-net-worth residential market. The property's appeal to institutional investors and finance professionals reflects broader demand among sophisticated buyers for premium South Beach locations characterized by ocean views and Art Deco design elements. The resumption of deal flow at Apogee after a two-year hiatus may signal renewed appetite in Miami's luxury residential sector among alternative investment professionals and high-net-worth individuals.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.